Total Laparoscopic HysterectomyASBPNCT05720884
Acupuncture for Blood Pressure Fluctuation During Total Laparoscopic Hysterectomy
A study testing acupuncture in people with Total Laparoscopic Hysterectomy, run by Ilsan Cha hospital at 1 site in South Korea.
Trial summary
The goal of this pilot clinical trial is to learn about efficacy of acupuncture about blood pressure fluctuation during total laparoscopic hysterectomy in patients with uterine fibroid. Read more about this study
- Who is it for?
- Ages 19 to 69 years
- Conditions the study is for
- Total Laparoscopic Hysterectomy
- What is being tested?
- acupuncture
- Type of treatment
- Medical device
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 35 participants
- Where
- 1 siteSouth Korea
- Study dates
- 23 Oct 2023to 31 Dec 2025
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 19 to 69 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- between age of 19 and 69,
- American Society of Anesthesiologists (ASA) class I or II,
- required surgical removal of uterus by a gynecology specialist,
- scheduled to have total laparoscopic hysterectomy in advance.
Who cannot join
- expected survival within 3 months,
- emergency operation which was not scheduled in advance,
- hypertension or hypotension that can significantly interfere with the study result,
- diagnosis of arrhythmia, such as atrial fibrillation, frequent ventricular or supraventricular premature beats,
- diagnosis of heart failure or valvular disease,
- anemia of hemoglobin < 12 g/dL,
Show all 15Show fewer
- incapable of surgery due to hemodynamic or medical reasons other than stated above,
- incapable of receiving acupuncture treatment on determined location,
- current use of gonadotropin-releasing hormone receptor agonists,
- current use of drugs that may interfere with the result, including steroids, immunosuppressants, and psychiatric disorders,
- significant comorbidities that may interfere with the interpretation of intervention efficacy or results, such as stroke, myocardial infarction, kidney disease, dementia, or epilepsy,
- pregnant, planning to be pregnant within study period, or breastfeeding,
- previous participation in any other clinical trial within 1 month of participation, planning to participate another clinical trial within 6 months after enrollment date, or planning to participate another clinical trial on follow-up period,
- fail to write the informed consent form voluntarily,
- being deemed to be unsuitable for participation.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Efficacy and Safety of Acupuncture for Blood Pressure Fluctuation During Total Laparoscopic Hysterectomy: a Randomized Controlled, Parallel-grouped Pilot Study
The goal of this pilot clinical trial is to learn about efficacy of acupuncture about blood pressure fluctuation during total laparoscopic hysterectomy in patients with uterine fibroid.
Participants will receive two times of acupuncture treatment before surgery and researchers will compare to see if acupuncture treatment would stabilize blood pressure fluctuation especially from induction time to post-incision moment.
Read the detailed description
After sufficient explanation about the purpose and methods of this clinical study by a researcher, the subject who voluntarily decided to participate and signed a written consent will be evaluated for eligibility at the screening visit. Eligible subjects will be determined as acupuncture group and a placebo control group according to the randomization. Acupuncture treatment is performed twice, one day before surgery and the same day.
On the day of surgery, after entering the operating room, monitoring equipments (non-invasive blood pressure monitor, pulse oxygen saturation, electrocardiogram, anesthesia depth sensor, neuromuscular monitor) will be installed and vital signs including pulse rate, blood pressure, oxygen saturation are measured.
Anesthesia was induced with an anesthetic (intravenous propofol 1-2.5 mg/kg, IV), an analgesic (remifentanyl 0.2mg/hr, IVF), and a muscle relaxant (intravenous rocuronium 0.6-1.2 mg/kg). After induction of anesthesia, anesthesiologist performed tracheal intubation maintaining an appropriate depth of anesthesia (Sedline < 50). Mechanical ventilation started keeping end-tidal CO2 pressure of 25-35 mmHg). Then, an additional venous tube was secured. Additional disinfection process was performed, surgery is prepared.
With the patient in the lithotomy position and under the general anesthesia, the abdomen was prepared, painted and draped with the usual manner. The uterine elevator was inserted. Skin incision was performed and trocar was inserted. The CO2 gas was infused to make pneumoperitoneum which pressure was reached to 12mmHg. Entering into the abdominal cavity, the patient position was changed to the Trendelenburg position. And then the pelvic cavity and whole abdomen were examined. Bilateral pelvic side wall triangles were opened in parallel to infundibulopelvic ligament and ureter dissection was done. The ureteral course was identified, and then the right round ligament and ovarian ligament were coagulated with bipolar endocoagulator, cut with endoscissors. The left sided uterine ligaments were manipulated with the same method as above. The bladder flap was pushed and posterior broad ligament was mobilized. Bilateral uterine vessels were skeletonized and bilateral uterine vessels were coagulated and then cut. Circumferential colpotomy was done with unipolar scissor, and the uterus was removed transvaginally and then vaginal cuff was closed intracorporeal continuous suture. Hemostasis and ureteral peristalsis were assured and abdominal cavity was irrigated with normal saline. The subcutaneous tissue and the skin were closed layer by layer. In all processes, a qualified anesthesiologist whose clinical experience of more than 10 years will control the analgesic or anesthetic injection rate and inhalation gas concentration to maintain the appropriate blood pressure and depth of anesthesia.
- Conditions
- Total Laparoscopic Hysterectomy
- Being tested
- acupuncture, placebo acupuncture
- Keywords
- general anesthesia, blood pressure fluctuation, acupuncture
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
acupunctureDevice
Acupuncture of a disposable, sterilized, stainless steel needle of 0.20 mm * 30 mm size (Dongbang medical, Boryeong, Rep of Korea) will be used.
placebo acupunctureDevice
Acupuncture of a disposable, sterilized, stainless steel needle of 0.20 mm * 30 mm size (Dongbang medical, Boryeong, Rep of Korea) will be used but in differene location.
| Study group | Role | What they receive |
|---|---|---|
| acupuncture group | Experimental | A total 10 acupoints of bilateral PC6, PC5, SP3, KI3, and ST36 will be chosen for the intervention group, also known as the acupuncture group. The depth of acupuncture will be varied by participant by participant. After acupuncture needles be inserted, the needles will be manually manipulated to obtain pre-determined sensation, the De Qi. Then, acupuncture will remain inserted for 20 minutes. Receives: Device: acupuncture |
| placebo group | Placebo comparator | Ten other points, which are not official acupoints and those are not on the median nerve or peroneal nerve, will be chosen for the placebo group. Receives: Device: placebo acupuncture |
What is being measured
The primary outcome is the main question the study is designed to answer.
changes in mean blood pressure
the difference between the highest mean blood pressure and the lowest mean blood pressure from the induction of anesthesia to the post-incision period
Measured: At operation time
Secondary outcomes (9)
blood pressures according to predetermined timepoints
systolic blood pressure, diastolic blood pressure and mean blood pressure values at entering operation room, induction time, intubation time, venous tube insertion, preparation time, skin incision, and gas inflation.
Measured: At operation time
incidence of hypotension
Total incidence count of hypotension events, determined as lower than 80% of baseline or systolic blood pressure below 90
Measured: At the end of operation moment
incidence of hypertension
Total incidence count of hypertension events, determined as systolic blood pressure over 160
Measured: At the end of operation moment
incidence of tachycardia according to predetermined timepoints
heart rate values at entering operation room, induction time, intubation time, venous tube insertion, preparation time, skin incision, and gas inflation.
Measured: At the end of operation moment
incidence of bradycardia according to predetermined timepoints
heart rate values at entering operation room, induction time, intubation time, venous tube insertion, preparation time, skin incision, and gas inflation.
Measured: At the end of operation moment
total use of remifentanil
Use of remifentanil dosage will be surrogate markers of stable general anesthesia.
Measured: At the end of operation moment
numeric rating scale for pain
numeric rating scale is a 11 point scale that defined point 0 as totally painless state, and point 10 as extreme pain as imaginable as possible.
Measured: before operation(operation date), at the end of operation moment
Spielberger's State-Trait Anxiety Inventory (STAI)
State-Trait Anxiety Inventory (STAI) consists of two categories, twenty items of questionnaire to assess state anxiety (STAI-S) and another twenty items to assess trait anxiety (STAI-T). STAI varies from a minimum score of 20 to a maximum score of 80. Lower scores means presence of less anxiety (no or low anxiety 20-37, moderate 38-44, and high anxiety 45-80).
Measured: before operation(operation date), at the end of operation moment
EuroQoL-5 Dimensions - 5 Levels (EQ-5D-5L)
The EQ-5D-5L is used to assess effects on patients' quality of life. The questionnaire consists of questions in five areas (mobility, self-care, usual activities, pain, and anxiety/depression) that ask about the patient's current state of health. Answers are provided on a 5-point Likert scale.
Measured: before operation(operation date), at the end of operation moment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Feb 2023
- Study start23 Oct 2023
- Primary completion4 Jun 2025
- Study completion31 Dec 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Total Laparoscopic HysterectomyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- acupuncture group and placebo group
- Masking
- Triple blind
- Who is masked
- Participant, Care provider, Outcomes assessor
- Enrolment
- 35 participants (actual)
Sponsor and investigators
- Lead sponsor
- Ilsan Cha hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Jee Young Lee, CHA University
- Investigators
- Jee Young Lee, Dr, Principal investigator, Cha Ilsan Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05720884
- Sponsor's protocol ID
- ICICC-CT-22-05
- Acronym
- ASBP
- Status last verified
- Mar 2026
- First submitted
- 20 Jan 2023
- Last updated
- 27 Mar 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: There is no plan to share individual participant data, since researchers considered privacy.
Publications
Lee JY, Roh JW, Han KH, Kim MJ, Na YJ, Yun BS, Lee J. Rationale for the Use of Acupuncture to Stabilize Blood Pressure Fluctuations During Total Laparoscopic Hysterectomy: Protocol for a Pilot Parallel-Group Randomized Clinical Trial. JMIR Res Protoc. 2025 Jul 22;14:e77009. doi: 10.2196/77009.
PubMed 40603084